You searched for "presentation"

2678 results found

The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy

The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...

Autofluorescence patterns in subretinal haemorrhages associated with neovascular age-related macular degeneration

The aim of this retrospective study was to describe the surgical results and fundus autofluorescence (FAF) patterns occurring in sub-macular haemorrhage (SMH) of duration <60 days in age-related macular degeneration (AMD). Notes from 39 eyes of 39 patients with SMH,...

Type 3 macular neovascularisation (MNV) due to age-related macular degeneration

This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...

Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report

Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...

Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy

Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...

Effective treatment for rare sight-threatening infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

Optometrist found guilty of manslaughter

To start our new Optometry section, editor Janet Pooley takes a look at the tragic death of Vincent Barker and asks what lessons can be learned. In August, Optometrist Honey Rose was found guilty of the manslaughter of eight-year-old Vincent...

Seven in ten UK adults support compulsory eye tests for drivers to improve road safety, new research reveals

The College of Optometrists and the Association of Optometrists say research shows “current vision checks aren’t keeping pace with what’s needed to keep everyone safe on the road” Seven in ten UK adults support calls for the introduction of mandatory...

Redefining the future of sight - Moorfields Eye Charity launches first major national funding initiative

New grants strategy aims to enable innovation at scale and transform eye health. Moorfields Eye Charity has launched a significant national funding initiative to accelerate the urgent development of new eye health treatments and interventions. The new Discovery and Translation...

Advanced level practice for ophthalmic nursing

The Royal College of Nursing (RCN) Ophthalmic Nursing Forum (ONF) is committed to clinical excellence through advancing ophthalmic nursing practice and supporting career development. With the increasing demand for ophthalmic services, advanced and specialist practice roles are vital to increase...

Orbis and FedEx team up on three-week training for Eye Care Professionals in Vietnam

This is the first surgical project for the Orbis Flying Eye Hospital in three years.

The Eyes Have It launches new report calling for a National Eye Care Plan for England to address surging patient demand

The Eyes Have It is a partnership of Macular Society, Fight for Sight / Vision Foundation, Royal National Institute of Blind People (RNIB), Association of Optometrists, The Royal College of Ophthalmologists and Roche Products Ltd.